Abstract | OBJECTIVE: Is it possible to reduce the recurrence rates of HPV-positive genital tract lesions by systemic interferon alfa-2a in addition to local therapy? METHODS: RESULTS: For the remaining 47 patients (16 were lost to follow-up) we found a significantly lower recurrence rate of 21% (5 of 24) in the group of interferon-treated patients compared to 52% (12 of 23) of patients treated without interferon. CONCLUSIONS: The systemic treatment of HPV-positive genital tract lesions with interferon alfa-2a in addition to CO2 laser surgery or cone biopsy seems to reduce the recurrence rates of HPV-positive lesions.
|
Authors | J Backe, T Roos, H Kaesemann, J Martius, M Ott |
Journal | Gynakologisch-geburtshilfliche Rundschau
(Gynakol Geburtshilfliche Rundsch)
Vol. 35
Issue 2
Pg. 79-84
( 1995)
ISSN: 1018-8843 [Print] Switzerland |
Vernacular Title | Lokaltherapie und adjuvante Interferontherapie bei genitalen Papillomvirusinfektionen. |
PMID | 7620386
(Publication Type: Journal Article)
|
Chemical References |
- Interferon alpha-2
- Interferon-alpha
- Recombinant Proteins
|
Topics |
- Adolescent
- Adult
- Biopsy
- Cervix Uteri
(pathology)
- Child
- Combined Modality Therapy
- Condylomata Acuminata
(pathology, therapy)
- Female
- Genital Neoplasms, Female
(pathology, therapy)
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha
(administration & dosage, adverse effects)
- Laser Therapy
- Middle Aged
- Neoplasm Recurrence, Local
(pathology, therapy)
- Neoplasm Staging
- Papillomaviridae
(drug effects)
- Papillomavirus Infections
(pathology, therapy)
- Recombinant Proteins
- Tumor Virus Infections
(pathology, therapy)
- Uterine Cervical Neoplasms
(pathology, therapy)
- Vaginal Neoplasms
(pathology, therapy)
- Vulvar Neoplasms
(pathology, therapy)
- Uterine Cervical Dysplasia
(pathology, therapy)
|